List of bibliographic references indexed by Motor Activity (drug effects)
Number of relevant bibliographic references: 40.
[0-20] [
0 - 20][
0 - 40][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000610 (2015) |
Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud] | Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) |
| 000678 (2015) |
Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni] | Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| 000867 (2014) |
Fariborz Rahimi [Iran] ; Carina Bee [Canada] ; Christian Duval [Canada] ; Patrick Boissy [Canada] ; Roderick Edwards [Canada] ; Mandar Jog [Canada] | Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease. |
| 000877 (2014) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada] | UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset. |
| 000959 (2014) |
Jackalina M. Van Kampen [Canada] ; David Baranowski [Canada] ; Denis G. Kay [Canada] | Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease |
| 000B60 (2014) |
Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada] | AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. |
| 001123 (2012) |
Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel Cyr | Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model. |
| 001152 (2012) |
Connie Marras [Canada] ; David Oakes [États-Unis] | Piecing together the puzzle of progression and mortality in Parkinson's
disease |
| 001191 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie | L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 001406 (2012) |
K. Martinu [Canada] ; C. Degroot [Canada] ; C. Madjar [Canada] ; A. P. Strafella [Canada] ; O. Monchi [Canada] | Levodopa influences striatal activity but does not affect cortical hyper‐activity in Parkinson’s disease |
| 001713 (2011) |
Sara Kost [Canada] ; Chao Sun ; Wei Xiong ; Kathryn Graham ; Carol E. Cass ; James D. Young ; Benedict C. Albensi ; Fiona E. Parkinson | Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice. |
| 001996 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie | Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 001E32 (2009) |
D. Litteljohn ; E. Mangano ; N. Shukla ; S. Hayley | Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat. |
| 002308 (2008) |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | Levodopa‐related motor complications—Phenomenology |
| 002491 (2007) |
Elena I. Miklyaeva [Canada] ; Ian Q. Whishaw ; Bryan Kolb | A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere. |
| 002806 (2006) |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors |
| 002834 (2006) |
Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada] | Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice |
| 002A09 (2005) |
K. Adam Baker [Canada] ; Ivar Mendez [Canada] | Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain |
| 002B51 (2005) |
Tom H. Johnston [Canada] ; Joohyung Lee [Canada] ; Jordi Gomez-Ramirez [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease |
| 002B62 (2004) |
Nicolas Lapointe [Canada] ; Michel St-Hilaire ; Maria-Grazia Martinoli ; Julie Blanchet ; Peter Gould ; Claude Rouillard ; Francesca Cicchetti | Rotenone induces non-specific central nervous system and systemic toxicity. |
| 002D83 (2003) |
Nancy Bélanger [Canada] ; Laurent Grégoire ; Paul Bédard ; Thérèse Di Paolo | Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Motor Activity (drug effects)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Motor Activity (drug effects)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Motor Activity (drug effects)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
